390 related articles for article (PubMed ID: 25266555)
21. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Rajkumar SV; Lacy MQ; Kyle RA
Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
[TBL] [Abstract][Full Text] [Related]
22. Asymptomatic monoclonal gammopathies.
Bories C; Jagannath S
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S78-86. PubMed ID: 25486961
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis and therapy of multiple myeloma: current aspects].
Betticher DC; Cerny T; Fey MF
Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
[TBL] [Abstract][Full Text] [Related]
24. Multiple myeloma: charging toward a bright future.
Katzel JA; Hari P; Vesole DH
CA Cancer J Clin; 2007; 57(5):301-18. PubMed ID: 17855486
[TBL] [Abstract][Full Text] [Related]
25. Multiple myeloma: future directions in autologous transplantation and novel agents.
Hari PN; McCarthy PL
Biol Blood Marrow Transplant; 2013 Jan; 19(1 Suppl):S20-5. PubMed ID: 23290439
[No Abstract] [Full Text] [Related]
26. The Tao of myeloma.
Boise LH; Kaufman JL; Bahlis NJ; Lonial S; Lee KP
Blood; 2014 Sep; 124(12):1873-9. PubMed ID: 25097176
[TBL] [Abstract][Full Text] [Related]
27. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.
Paiva B; Vídriales MB; Rosiñol L; Martínez-López J; Mateos MV; Ocio EM; Montalbán MÁ; Cordón L; Gutiérrez NC; Corchete L; Oriol A; Terol MJ; Echeveste MA; De Paz R; De Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Granell M; Gorosquieta A; Alegre A; Orfao A; Lahuerta JJ; Bladé J; San Miguel JF;
Leukemia; 2013 Oct; 27(10):2056-61. PubMed ID: 23743858
[TBL] [Abstract][Full Text] [Related]
28. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
29. The current status and future of multiple myeloma in the clinic.
Jagannath S; Kyle RA; Palumbo A; Siegel DS; Cunningham S; Berenson J
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):28-43. PubMed ID: 20223727
[TBL] [Abstract][Full Text] [Related]
30. Current strategies for treatment of relapsed/refractory multiple myeloma.
Laubach JP; Voorhees PM; Hassoun H; Jakubowiak A; Lonial S; Richardson PG
Expert Rev Hematol; 2014 Feb; 7(1):97-111. PubMed ID: 24471924
[TBL] [Abstract][Full Text] [Related]
31. The progress in multiple myeloma.
Hatjiharissi P
Hell J Nucl Med; 2023; 26 Suppl():30-35. PubMed ID: 37658559
[TBL] [Abstract][Full Text] [Related]
32. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
Paiva B; Pérez-Andrés M; Vídriales MB; Almeida J; de las Heras N; Mateos MV; López-Corral L; Gutiérrez NC; Blanco J; Oriol A; Hernández MT; de Arriba F; de Coca AG; Terol MJ; de la Rubia J; González Y; Martín A; Sureda A; Schmidt-Hieber M; Schmitz A; Johnsen HE; Lahuerta JJ; Bladé J; San-Miguel JF; Orfao A; ;
Leukemia; 2011 Apr; 25(4):697-706. PubMed ID: 21252988
[TBL] [Abstract][Full Text] [Related]
33. Multiple myeloma : recent progress in diagnosis and treatment.
Chou T
J Clin Exp Hematop; 2012; 52(3):149-59. PubMed ID: 23269074
[TBL] [Abstract][Full Text] [Related]
34. Bone Tumors: Multiple Myeloma.
Kane SF
FP Essent; 2020 Jun; 493():30-35. PubMed ID: 32573185
[TBL] [Abstract][Full Text] [Related]
35. Multiple myeloma: a model for scientific and clinical progress.
San Miguel J
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):1-7. PubMed ID: 25696828
[TBL] [Abstract][Full Text] [Related]
36. Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
Br J Haematol; 2008 Apr; 141(2):205-11. PubMed ID: 18318761
[TBL] [Abstract][Full Text] [Related]
37. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
38. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
Rajkumar SV; Buadi F
Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
[TBL] [Abstract][Full Text] [Related]
39. Management of multiple myeloma in the newly diagnosed patient.
Mateos MV; San Miguel JF
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):498-507. PubMed ID: 29222298
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of effectiveness of novel therapies in multiple myeloma.
Bianchi G; Ghobrial IM
Leuk Lymphoma; 2013 Feb; 54(2):229-41. PubMed ID: 22897729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]